- €105.31m
- €153.13m
- €91.55m
- 30
- 51
- 39
- 31
R2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 12.8 | 22.7 | 36.3 | 50.2 | 91.6 |
Cost of Revenue | |||||
Gross Profit | 7.17 | 12.1 | 17.6 | 20.8 | 33 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 10.8 | 17.8 | 27.2 | 39.4 | 79.3 |
Operating Profit | 2.09 | 4.89 | 9.1 | 10.7 | 12.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.04 | 4.86 | 8.82 | 10.7 | 9.22 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1.47 | 3.47 | 7.84 | 7.5 | 6.69 |
Net Income Before Extraordinary Items | |||||
Net Income | 1.47 | 3.47 | 7.84 | 7.5 | 6.69 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 1.47 | 3.47 | 7.84 | 7.5 | 6.69 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.06 | 0.159 | 0.32 | 0.305 | 0.682 |
Dividends per Share |